Fulgent Genetics Inc (FLGT)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SERVICES-MEDICAL LABORATORIES

4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY, CA 91780

Fulgent Genetics, Inc. operates as a technology company. The Company develops a proprietary technology platform that integrates sophisticated data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools, and integrated laboratory processes. Fulgent Genetics offers genetic testing to provide physicians with clinically diagnostic information.

Data based on most recent fiscal year report
Market Cap63.617 Million Shares Outstanding17.82 Million Avg Volume62.551 Thousand
1-Yr BETA vs S&P TR0.547 Current Ratio10.98 Quick Ratio10.98
View SEC Filings from FLGT instead.
Q2 2019 All Institutions Hedge Funds 1
To trade FLGT now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 14 4 (0.41%)
Aggregate 13F shares on 06/30/2019: 1.301 Million 759.812 Thousand
Aggregate 13F shares on 03/31/2019: 1.243 Million 688.869 Thousand
Percent change: 4.70% 10.30%
Funds creating new positions:
Funds Adding to an existing position: 7 3
Funds closing out their position: 2
Funds reducing their position: 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding FLGT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

12.4 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HSIEH MING

  • Director
0 2019-08-15 3

KIM PAUL CFO AND TREASURER

  • Officer
401,222 2019-08-12 6

GAO HANLIN CSO

  • Officer
  • 10% Owner
1,782,659 2019-08-01 1

MARSH LINDA

  • Director
0 2019-08-01 2

BOLGER JOHN C

  • Director
0 2019-05-30 1

MULAY JAMES

  • Director
0 2019-05-30 1

YEN YUN

  • Director
0 2018-08-04 0

FULGENT GENETICS, INC.

  • Director
6,842 2017-05-16 0

XI LONG USA, INC.

  • 10% Owner
2,025,623 2016-09-30 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KIM PAUL - Officer CFO AND TREASURER

2019-08-12 S 11,028 $11.52 d 401,222 401,222.00 direct

KIM PAUL - Officer CFO AND TREASURER

2019-08-12 S 1,361 $11.34 d 412,250 401,222.00 direct

GAO HANLIN - Officer - > 10% Owner CSO

2019-08-01 A 15,000 a 1,782,659 1,782,659.00 direct

KIM PAUL - Officer CFO AND TREASURER

2019-08-01 A 15,000 a 413,611 413,611.00 direct

MARSH LINDA - Director

2019-08-01 A 20,000 a 20,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments